SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Sanabria Bohorquez Sandra M.) "

Sökning: WFRF:(Sanabria Bohorquez Sandra M.)

  • Resultat 1-3 av 3
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Bernal, Ximena E., et al. (författare)
  • Empowering Latina scientists
  • 2019
  • Ingår i: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 363:6429, s. 825-826
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
2.
  • Erondu, Ngozi, et al. (författare)
  • Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults
  • 2006
  • Ingår i: Cell Metabolism. - : Elsevier BV. - 1550-4131. ; 4:4, s. 275-282
  • Tidskriftsartikel (refereegranskat)abstract
    • Neuropeptide Y (NPY) is a potent orexigenic neuropeptide, and antagonism of NPY Y1 and NPY Y5 receptors (NPYxR) is considered a potentially important anti-obesity drug target. We tested the hypothesis that blockade of the NPY5R will lead to weight loss in humans using MIK-0557, a potent, highly selective, orally active NPY5R antagonist. The initial series of experiments reported herein, including a multiple-dose positron-emission tomography study and a 12 week proof-of concept/dose-ranging study, suggested an optimal MK-0557 dose of 1 mg/day. The hypothesis was then tested in a 52 week, multicenter, randomized, double-blind, placebo-controlled trial involving 1661 overweight and obese patients. Although statistically significant at 52 weeks, the magnitude of induced weight loss was not clinically meaningful. These observations provide the first clinical insight into the human NPY-energy homeostatic pathway and suggest that solely targeting the NPY5R in future drug development programs is unlikely to produce therapeutic efficacy.
  •  
3.
  • Blennow, Kaj, et al. (författare)
  • Cerebrospinal fluid tau fragment correlates with tau PET : a candidate biomarker for tangle pathology
  • 2020
  • Ingår i: Brain : a journal of neurology. - : Oxford University Press (OUP). - 1460-2156. ; 143:2, s. 650-660
  • Tidskriftsartikel (refereegranskat)abstract
    • To date, there is no validated fluid biomarker for tau pathology in Alzheimer's disease, with contradictory results from studies evaluating the correlation between phosphorylated tau in CSF with tau PET imaging. Tau protein is subjected to proteolytic processing into fragments before being secreted to the CSF. A recent study suggested that tau cleavage after amino acid 368 by asparagine endopeptidase (AEP) is upregulated in Alzheimer's disease. We used immunoprecipitation followed by mass spectrometric analyses to evaluate the presence of tau368 species in CSF. A novel Simoa® assay for quantification of tau368 in CSF was developed, while total tau (t-tau) was measured by ELISA and the presence of tau368 in tangles was evaluated using immunohistochemistry. The diagnostic utility of tau368 was first evaluated in a pilot study (Alzheimer's disease = 20, control = 20), then in a second cohort where the IWG-2 biomarker criteria were applied (Alzheimer's disease = 37, control = 45), and finally in a third cohort where the correlation with 18F-GTP1 tau PET was evaluated (Alzheimer's disease = 38, control = 11). The tau368/t-tau ratio was significantly decreased in Alzheimer's disease (P < 0.001) in all cohorts. Immunohistochemical staining demonstrated that tau fragments ending at 368 are present in tangles. There was a strong negative correlation between the CSF tau368/t-tau ratio and 18F-GTP1 retention. Our data suggest that tau368 is a tangle-enriched fragment and that the CSF ratio tau368/t-tau reflects tangle pathology. This novel tau biomarker could be used to improve diagnosis of Alzheimer's disease and to facilitate the development of drug candidates targeting tau pathology. Furthermore, future longitudinal studies will increase our understanding of tau pathophysiology in Alzheimer's disease and other tauopathies.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-3 av 3
Typ av publikation
tidskriftsartikel (3)
Typ av innehåll
refereegranskat (2)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Brinkmalm, Gunnar (1)
Portelius, Erik, 197 ... (1)
Hansson, Oskar (1)
Blennow, Kaj (1)
Långström, Bengt (1)
Kvartsberg, Hlin, 19 ... (1)
visa fler...
Zetterberg, Henrik (1)
Castaneda-Gomez, Lau ... (1)
Guedes, Thais (1)
Zapata, Felipe (1)
Lashley, Tammaryn (1)
Orizaola, German (1)
Höglund, Kina, 1976 (1)
Dick, Christopher W. (1)
Chen, Chun (1)
Pimiento, Catalina (1)
Ortiz-Barrientos, Da ... (1)
Bernal, Ximena E. (1)
Rojas, Bibiana (1)
Pinto-E, Maria Aleja ... (1)
Mendoza-Henao, Angel ... (1)
Herrera-Montes, Adri ... (1)
Isabel Herrera-Monte ... (1)
Caceres Franco, Andr ... (1)
Ceron-Souza, Ivania (1)
Paz, Andrea (1)
Vergara, Daniela (1)
Barragan Contreras, ... (1)
Salazar, Camilo (1)
Bohorquez Alonso, Ma ... (1)
Sanchez, Adriana (1)
Olaya-Castro, Alexan ... (1)
Urbina-Cardona, Nico ... (1)
Guayasamin, Juan M. (1)
Uy, Floria Mora-Kepf ... (1)
Feris, Faride Lamadr ... (1)
Franco-Orozco, Barba ... (1)
Munoz, Martha M. (1)
Patricia Rincon-Diaz ... (1)
Sanchez Herrera, Mel ... (1)
Betancourth-Cundar, ... (1)
Tarvin, Rebecca D. (1)
Marquez, Roberto (1)
Lopez-Aguirre, Camil ... (1)
Ron, Santiago R. (1)
Ramirez, Santiago (1)
Paez-Vacas, Monica (1)
Gaitan-Espitia, Juan ... (1)
Vianna, Juliana A. (1)
Varela-Jaramillo, An ... (1)
visa färre...
Lärosäte
Göteborgs universitet (1)
Uppsala universitet (1)
Lunds universitet (1)
Chalmers tekniska högskola (1)
Karolinska Institutet (1)
Språk
Engelska (3)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (2)
Medicin och hälsovetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy